Renal Transplantation in Autosomal Dominant Polycystic Kidney Disease

Andrzej Kulesza,1 Longin Niemczyk,2 *Mariusz Niemczyk1

1. Department of Immunology, Transplant Medicine, and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
2. Department of Nephrology, Dialysis, and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
*Correspondence to mariuszniemczyk@wp.pl
Andrzej Kulesza and Longin Niemczyk contributed equally to this work.

Disclosure: The authors have declared no conflicts of interest.
Received: 10.02.15 Accepted: 10.04.15
Citation: EMJ Nephrol. 2015;3[1]:56-62.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 1 in 1,000 people in the general population. The natural history of ADPKD includes the progression of chronic kidney disease to end-stage renal disease (ESRD) in a large proportion of patients. Renal transplantation is the treatment modality of choice in these patients. However, there are some specific issues that should be addressed in ADPKD, and the aim of the current review is to describe the issues that need to be considered in the pre and post-transplant management of ADPKD patients, excluding routine procedures.

Download (PDF, 114KB)

Comments are closed.